The capsular polysaccharide is a critical virulence factor for group B streptococci associated with human infections, yet little is known about capsule biosynthesis. We detected CMP-Neu5Ac synthetase, the enzyme which activates N-acetylneuraminic acid (Neu5Ac, or sialic acid) for transfer to the nascent capsular polysaccharide, in multiple group B streptococcus serotypes, all of which elaborate capsules containing Neu5Ac. CMP-Neu5Ac synthetase isolated from a high-producing type lb strain was purified 87-fold. The enzyme had apparent Km values of 7.6 for Neu5Ac and 1.4 for CTP and a pH optimum of 8.3 to 9.4, required magnesium, and was stimulated by dithiothreitol. This is the first characterization of an enzyme involved in group B streptococcus capsular polysaccharide biosynthesis.
Strains of group B streptococci (GBS) associated with neonatal sepsis and meningitis elaborate one of several capsular polysaccharides, all of which contain Neu5Ac (sialic acid) (1, 3, 11, 14, 16) . The presence of Neu5Ac in the type III capsule enhances resistance to phagocytosis, a phenomenon attributed at least partly to inhibition of the alternative pathway of complement by Neu5Ac (2, 5) . Previously, we showed that CMP-Neu5Ac synthetase activity was essential for sialylation of the capsular polysaccharide in serotype III GBS (15) . In this report, we demonstrate CMP-Neu5Ac synthetase activity in multiple GBS serotypes, describe partial purification and characterization of the enzyme, and compare it with analogous enzymes in Escherichia coli K1 and Neisseria meningitidis group C.
(Part of this work was presented at the American Federation for Clinical Research Meeting, Baltimore, Md., May 1992.) Activity in different GBS serotypes. Whole-cell lysates of strains from four major serotypes of GBS were prepared essentially as described previously (15) : bacterial pellets were washed in 50 mM Tris-HCl buffer (pH 7.6), resuspended in the same buffer to approximately 0.5% of the original broth culture volume, and lysed by shaking with glass beads (Vibrogen cell mill) for 20 min with ice water cooling. Lysates were assayed for the presence of CMP-Neu5Ac synthetase activity as described previously (15 Partial purification of GBS CMP-Neu5Ac synthetase. Because serotype Tb strains had significantly greater activity than did other serotypes tested, GBS lb strain 7357b was selected for purification of the enzyme. Purification was performed at 40C. After cell lysis by shaking with glass beads, the cell lysate was separated at 100,000 X g for 60 min into soluble (supernatant) and particulate (pellet) fractions. The portion of total cell protein separating into the soluble fraction varied from 33 to 90%. Protein in the soluble lysate was precipitated sequentially at 30 and 60% saturated ammonium sulfate (6) . More than 99% of the total activity precipitated between 30 and 60% saturated ammonium sulfate. This fraction was dialyzed and applied to a column (2.5 by 30 cm) of DEAE-Sephacel. Bound proteins were eluted with a linear gradient of 0 to 0.35 M NaCl followed by a step elution at 0.6 M NaCl. CMP-Neu5Ac synthetase eluted at 0.21 to 0.27 M NaCl. Fractions containing enzyme activity were pooled, dialyzed against 10 mM Tris HC1 (pH 7.6), lyophilized, and stored at -80°C. Specific activity of the enzyme after ion-exchange chromatography was 0.35 ,umol of CMP-Neu5Ac per mg of protein per min, an 87-fold purification compared with the starting cell lysate ( Table 2 ). The apparent increase in total activity with the final purification step may reflect the removal of an enzyme inhibitor from Further purification was attempted by a variety of methods including liquid-phase isoelectric focusing and preparative nondenaturing gel electrophoresis, without a significant increase in enzyme specific activity. Affinity chromatography purifications on CDP-ethanolamine-Sepharose 4b and on Orange A Matrex dye resin, methods used to purify CMPNeuSAc synthetase from E. coli K1 (7, 9, 10), were not effective for purification of the GBS enzyme. GBS CMP-Neu5Ac synthetase did not bind to these affinity resins or to other dye ligands (RDL-9 affinity chromatography media kit; Sigma). These results suggest that the streptococcal enzyme differs from that in E. coli K1 in its affinity for these ligands. The 87-fold purification of the GBS enzyme is lower than the degree of purification achieved for CMP-Neu5Ac synthetase from N. meningitidis (403-fold) and E. coli (419-fold), although comparable methods were used for the meningococcal enzyme.
Characterization of CMP-Neu5Ac synthetase. The DEAESephacel-purified CMP-Neu5Ac synthetase from serotype Ib GBS was stable and sufficiently active to permit substantial characterization of the enzyme: 83% of the activity was recovered after storage for 4 weeks at pH 7.6 and 4°C. Activity was 100% stable at -80°C for 8 months, and the enzyme tolerated flash freezing and lyophilization.
Enzyme activity was undetectable at 4°C and maximal at 25 to 37°C but decreased by 88% at 42°C. It was irreversibly inactivated after boiling. GBS CMP-Neu5Ac synthetase activity was maximal at pH 8.3 to 9.4, consistent with pH optima reported for E. coli K1, N. meningitidis group C, and eukaryotic systems from which CMP-Neu5Ac synthetase had been completely or partially purified (4) . No enzyme product was detected when ATP, GTP, UTP, and dCTP were substituted for CTP in the assay. Magnesium was required for optimal CMP-Neu5Ac synthetase activity. Maximal activity was measured at or above 20 mM MgCl2. Substitution with manganese gave partial activity; calcium and zinc were not effective substitutes. The requirement for a divalent cation, particularly magnesium, has been universally observed for both prokaryotic and eukaryotic CMP-Neu5Ac synthetase enzymes (4). Elimination of dithiothreitol from the assay mixture caused a 75% reduction in activity. This result suggested that activity of the GBS CMP-Neu5Ac synthetase was stimulated by but not dependent upon sulfhydryl reduction, unlike CMP-Neu5Ac synthetase in N. meningitidis but comparable to activity in sheep brains (8, 13) .
Kinetic studies demonstrated that synthesis of CMP- 7 .6 and 1.4 mM, respectively. These concentrations of Neu5Ac and of CTP resulting in halfmaximal activity of the GBS enzyme are comparable to the Kms for these substrates in E. coli K1 (10) . Table 3 summarizes and compares features of GBS CMP-Neu5Ac synthetase activity with those from E. coli K1 and N. meningitidis group C.
We have shown previously that CMP-Neu5Ac synthetase is required for biosynthesis of the GBS type III polysaccharide. In the present work, we demonstrate that GBS bearing diverse Neu5Ac-containing capsular polysaccharides all contain CMPNeuSAc synthetase activity. The enzyme was partially purified from a type Ib GBS strain, and its properties were found to be similar, though not identical, to those of CMP-Neu5Ac synthetases in other bacterial species bearing NeuSAc-rich capsules. These studies of GBS CMP-Neu5Ac synthetase are the first to characterize an essential enzyme in GBS capsular polysaccharide biosynthesis.
